DOSEF (Doseology Sciences) Beta: 2.6081 (As of Jun. 24, 2026)


DOSEF Doseology Sciences Inc DOSEF
33 GF Score
Price $0.11
GF Value $0.29
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Doseology Sciences Beta?

Doseology Sciences DOSEF -16.16% 33 Beta is 2.6081 as of Jun. 24, 2026. GuruFocus rates DOSEF with a GF Score™ of 33/100 and a GF Value™ of $0.29 (Possible Value Trap). The stock has 4 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-24), Doseology Sciences's Beta is 2.6081.


Doseology Sciences  (OTCPK:DOSEF) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Doseology Sciences Beta Related Terms


Doseology Sciences Beta Historical Data

* Premium members only.

The historical data trend for Doseology Sciences's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Doseology Sciences Beta Chart

Doseology Sciences Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Beta
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 2.96

Doseology Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 2.96 4.19 4.61 4.27

DOSEF vs VRTX, REGN, ALNY: Beta Comparison

For the Biotechnology subindustry, Doseology Sciences's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Doseology Sciences Beta vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Doseology Sciences's Beta distribution charts can be found below:

* The bar in red indicates where Doseology Sciences's Beta falls into.


DOSEF
33GF Score
Doseology Sciences Inc DOSEF
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Doseology Sciences Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 2.6081 mean?
Doseology Sciences (DOSEF) has a Beta of 2.6081 as of Jun. 24, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Doseology Sciences and its competitors.
Is Doseology Sciences' Beta too high?
Doseology Sciences' current Beta is 2.6081. Overall, Doseology Sciences has a GF Score™ of 33/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Doseology Sciences' Beta compare to VRTX and REGN?
Doseology Sciences' Beta of 2.6081 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Biotechnology company?
A good Beta depends on the Biotechnology industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Doseology Sciences and its competitors. Doseology Sciences's current Beta is 2.6081. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Doseology Sciences stock overvalued right now?
Based on GuruFocus' analysis, Doseology Sciences (DOSEF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.29, compared to a current price of $0.11 — trading 61.3% below its estimated fair value. The current Beta is 2.6081. Doseology Sciences' overall GF Score™ is 33/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Doseology Sciences (DOSEF), the current Beta is 2.6081 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Doseology Sciences (DOSEF) Overvalued in 2026?

Based on GuruFocus' analysis, Doseology Sciences stock appears to be undervalued. The current stock price of $0.11 is trading 61.3% below its estimated GF Value™ of $0.29. GuruFocus considers Doseology Sciences to be Possible Value Trap.

Key valuation signals for DOSEF:

  • Beta: 2.6081
  • GF Value™: $0.29 vs. price of $0.11 (61.3% below fair value)
  • GF Score™: 33/100 with 4 warning signs

No single metric tells the full story. See the DOSEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Doseology Sciences Business Description

Other Exchanges MOOD:Canada
Address 9-3151 Lakeshore Road, Suite 305, Kelowna, BC, CAN, V1W 3S9
Doseology Sciences Inc is a diversified life sciences company, on a mission to reimagine mental health therapies through innovation, technology and sustainability. With a focus on the psychedelic and non-psychedelic compounds, also sale of its branded functional mushroom products. It offers cutting-edge therapeutic products and services, with the focus of making a meaningful impact on the mental health pandemic and improving overall health. Geographically earns it revenue from Canada.
33GF Score

Get the complete analysis for DOSEF

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.11
Price
$0.29
GF Value